Chie Satokawa

Title: Chie Satokawa: Innovator in Biochemical Assays

Introduction

Chie Satokawa is a notable inventor based in Koriyama, Japan. She has made significant contributions to the field of biochemical assays, particularly through her innovative patent related to the GPT assay.

Latest Patents

Chie Satokawa holds a patent for a reagent used in a two-reagent kit designed for assaying GPT. This kit operates by acting GPT on L-alanine and α-ketoglutarate in the presence of pyridoxal phosphate. The process converts the resulting pyruvate into lactate with the help of L-lactate dehydrogenase (LDH) and reduced nicotinamide adenine dinucleotide (NADH). The measurement of GPT is based on the decrement of NADH. The kit comprises a first reagent and a second reagent, where one contains pyridoxal phosphate, L-alanine, α-ketoglutarate, LDH, and NADH, while the other contains L-alanine without pyridoxal phosphate. This GPT assay kit is noted for its stability over an extended period.

Career Highlights

Chie Satokawa is associated with Nitto Boseki Co., Ltd., where she has been able to apply her expertise in biochemical research and development. Her work has contributed to advancements in diagnostic tools that are essential in medical laboratories.

Collaborations

Chie has collaborated with notable colleagues, including Yoshiro Sato and Ryo Kojima. These collaborations have fostered a productive environment for innovation and development in their respective fields.

Conclusion

Chie Satokawa's contributions to the field of biochemical assays through her innovative patent demonstrate her commitment to advancing medical diagnostics. Her work continues to impact the industry positively.